Flagship Pioneering Inc. - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 40 filers reported holding EVELO BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Flagship Pioneering Inc. ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$9,112,219
-88.8%
50,427,3280.0%0.35%
-86.3%
Q4 2022$81,188,000
-23.0%
50,427,3280.0%2.59%
-41.6%
Q3 2022$105,393,000
-0.9%
50,427,3280.0%4.44%
+10.7%
Q2 2022$106,401,000
+36.3%
50,427,328
+119.0%
4.01%
+118.7%
Q1 2022$78,072,000
-44.2%
23,030,0690.0%1.83%
-15.2%
Q4 2021$139,793,000
-13.8%
23,030,0690.0%2.16%
+27.3%
Q3 2021$162,131,000
-48.8%
23,030,0690.0%1.70%
-58.0%
Q2 2021$316,433,000
+28.4%
23,030,0690.0%4.04%
+2.4%
Q1 2021$246,421,000
-11.0%
23,030,069
+0.6%
3.95%
-21.7%
Q4 2020$276,862,000
+129.4%
22,900,0690.0%5.04%
+51.2%
Q3 2020$120,684,000
+7.6%
22,900,0690.0%3.33%
+2.3%
Q2 2020$112,210,000
+63.7%
22,900,069
+25.6%
3.26%
+1.5%
Q1 2020$68,558,000
-7.4%
18,233,4030.0%3.21%
-22.4%
Q4 2019$74,027,000
-33.4%
18,233,4030.0%4.14%
-32.0%
Q3 2019$111,224,000
-32.1%
18,233,4030.0%6.08%
-14.2%
Q2 2019$163,736,000
+12.3%
18,233,4030.0%7.09%
+28.4%
Q1 2019$145,867,000
-38.5%
18,233,4030.0%5.52%
-52.3%
Q4 2018$237,216,000
+6.8%
18,233,4030.0%11.58%
-21.1%
Q3 2018$222,083,000
+3.2%
18,233,4030.0%14.68%
-64.4%
Q2 2018$215,154,00018,233,40341.21%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 3,063,505$37,038,00014.47%
Mayo Clinic 484,953$5,863,0007.05%
Flagship Pioneering Inc. 22,900,069$276,862,0005.04%
Trustees of Columbia University in the City of New York 113,850$1,376,0001.84%
Alphabet Inc. 1,060,495$12,821,0000.62%
Artal Group S.A. 700,000$8,463,0000.18%
Larson Financial Group LLC 28,353$343,0000.12%
PEDDOCK CAPITAL ADVISORS, LLC 3,663$44,0000.02%
CREDIT SUISSE AG/ 2,705,511$32,710,0000.02%
FMR LLC 6,803,365$82,253,0000.01%
View complete list of EVELO BIOSCIENCES INC shareholders